Calcium antagonists in clinical medicine
著者
書誌事項
Calcium antagonists in clinical medicine
Hanley & Belfus , Mosby-Year Book, c1992
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
PRIORITY 3
Includes bibliographical references and index
内容説明・目次
内容説明
This is an in-depth review of the multitude of clinical applications already known and in practice for the class of drugs called calcium antagonists or calcium blockers (e.g. diltiazem, nifedipine, verapamil, etc). The use of these drugs overlaps several specialities, which are represented in this book by contributors from these fields. This book is intended for general internists, cardiologists, nephrologists, clinical pharmacologists and gastroenterologists.
目次
- Biochemical and pharmacological differences among calcium antagonists and their clinical implications
- calcium function in vascular smooth muscle and its relationship to hypertension
- pharmacokinetics of calcium antagonists - implications for therapy
- haemodynamic effects of calcium antagonists in hypertension
- arterial compliance and effect of calcium antagonists
- myocardial and vascular responses to calcium antagonists - implications for cardiovascular disorders
- cardiac effects of calcium antagonists in hypertension
- vasoprotective effects of calcium antagonists in experimental models of ischemia
- the pharmacotherapy of myocardial infarction - current perspectives
- the antiarrhythmic effects of calcium antagonists
- calcium antagonists in the management of hypertension
- calcium anatagonists and the gastrointestinal tract
- calcium antagonists - potential role in pulmonary diseases
- calcium antagonists and the cerebral circulation
- insulin-glucoregulatory hormones - implications for antihypertensive therapy
- calcium antagonists and the kidney
- - implications for renal protection
- abnormalities of calcium and the diabetic, hypertensive patient - implications for renal preservation
- clinical benefits of calcium antagonists in renal transplant recipients
- interactions of the endothelium and messangium in glomerular injury - amelioration by calcium antagonists.
「Nielsen BookData」 より